Literature DB >> 4930603

Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.

H P Porter, F R Simon, C E Pope, W Volwiler, L F Fenster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4930603     DOI： 10.1056/NEJM197106172842404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.

Authors:  Shinji Furuya; Joseph A Cichocki; Kranti Konganti; Kostiantyn Dreval; Takeki Uehara; Yuuki Katou; Hisataka Fukushima; Hiroshi Kono; Igor P Pogribny; Josepmaria Argemi; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

2.  Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status.

Authors:  Ashwani K Singal; Ishmeet Walia; Anjna Singal; Roger D Soloway
Journal:  World J Hepatol       Date:  2011-08-27

3.  Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.

Authors:  Kang Ho Kim; Jae Man Lee; Ying Zhou; Sanjiv Harpavat; David D Moore
Journal:  Mol Endocrinol       Date:  2016-06-29

4.  Influence of steroids on urea-cycle enzymes in chronic human liver disease.

Authors:  K P Maier; H Talke; H Heimsoeth; W Gerok
Journal:  Klin Wochenschr       Date:  1978-03-15

5.  Alcoholic liver injury.

Authors:  R Williams; M Davis
Journal:  Proc R Soc Med       Date:  1977-05

Review 6.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 7.  Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials.

Authors:  Chao-Hui Yu; Cheng-Fu Xu; Hua Ye; Lan Li; You-Ming Li
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

8.  Alcoholic hepatitis: should we combine old drugs for better results?

Authors:  Joaquin Cabezas; Ramon Bataller
Journal:  Hepatol Int       Date:  2016-09-15       Impact factor: 6.047

9.  CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.

Authors:  Silvia Affò; Oriol Morales-Ibanez; Daniel Rodrigo-Torres; José Altamirano; Delia Blaya; Dianne H Dapito; Cristina Millán; Mar Coll; Jorge M Caviglia; Vicente Arroyo; Juan Caballería; Robert F Schwabe; Pere Ginès; Ramón Bataller; Pau Sancho-Bru
Journal:  Gut       Date:  2014-01-10       Impact factor: 23.059

Review 10.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.